U.S. Clinical Nutrition Market - Industry Outlook & Forecast 2022-2027

List of Tables

The U.S. clinical nutrition market is expected to grow at a CAGR of 5.49% during 2022-2027.

MARKET OUTLOOK

The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market. The personalization and targeted solution approach stand with specific formulations that fulfill the need for nutritional support for patients suffering from chronic diseases and associated illnesses. In addition, the COVID-19 pandemic positively influenced the innovation in targeted and personalized clinical nutrition solutions. On another side, the increasing birth rate and the rising demand for milk-based nutritional support products by infants and toddler gives new aspects for vendors in the U.S. clinical nutrition market.
Clinical nutrition, known as medical nutrition, is the practice of analyzing and identifying whether an individual is consuming an adequate amount of nutrients for health. It can also be defined as the study of an overall analysis relationship between ingested meals and the well-being of a person's body. Clinical nutrition prioritizes the management of nutritional adjustment and helps diagnose and prevent nutritional level changes in the human body suffering from chronic conditions.
The U.S. government implements a tremendous breadth and depth of initiatives relevant to the country's nutrition level. So, the increasing government initiatives to improve the country's nutritional health and the rising concern about food insecurity across US families are expected to drive significant U.S. clinical nutrition market growth. In addition, the increasing geriatric population and chronic disease prevalence are constantly fueling industry growth. Obesity, hypertension, gastrointestinal disorders, CVD, and other primary health conditions primely accelerate the country's malnutrition rate, creating a high demand for clinical nutrition. However, there are some limitations to the industry growth, like potential side-effects associated with clinical nutrition and challenges in enteral nutrition deliveries, pediatric ICU patients, and more, hampering the industry growth.

MARKET TRENDS & DRIVERS

Increasing Demand for the Personalized and Targeted Clinical Nutrition

Personalized clinical nutrition is one of the trending approaches in clinical nutrition to fulfill the nutritional demand of every individual patient suffering from specific conditions. The targeted nutrition innovations deliver promising opportunities in medical practices and consumer and food production companies. Innovation in targeted and personalized solutions continues to grow and evolve rapidly in recent years with the increasing consumer demand from food systems to support their health and well-being. In addition, there is an increase in the number of digital tools in the research phase to calculate the nutrition requirement, scan the food based on appearance and help the individuals monitor their nutrition intake. This will further revolutionize the U.S. clinical nutrition market in the future.

Increasing Demand For The Infant Nutrition

One of the significant concerns in infants and toddlers arising rapidly in the US is the low-weight birth rate. About one in 12 babies is born with a low birth rate in the US. Increasing infant birth rates with lower weight delivers significant industry growth opportunities in milk-based nutritional products for U.S. clinical nutrition market players. Milk-based nutritional products are not new in the industry, but increasing demand and high competition among the industry players resulted in innovative product deliveries in recent years.
In 2021, the North American Based Organization Nutricia (by Danone) got approval for the new infant nutrition product Fortini from US FDA. This product is developed to support children living with the risk of growth deficiencies and those with increased energy requirements.

SEGMENTATION ANALYSIS

INSIGHTS BY ROUTE OF ADMINISTRATION

The U.S. clinical nutrition market by route of administration is segmented into oral, enteral, and parenteral, of which the oral segment dominated the industry with a higher share in 2021; due to the higher preference. At homecare, the oral route of administering clinical nutrition solutions is highly preferred among the pediatric population. The oral route of administration accounted for a higher 45.51% industry share.

In 2021, the enteral segment showed dominance over the parenteral segment, with a 36.36% share in the U.S. clinical nutrition market. Enteral nutrition is one of the vital parts of nutrition therapy when the patient cannot meet the nutritional demand by oral intervention. Enteral nutrition is commonly delivered from pediatric to geriatric populations when the patient suffers from gastrointestinal disease.

Segmentation by Route of Administration

Oral
Enteral nutrition
Parenteral Nutrition

INSIGHTS BY PRODUCT

The U.S. clinical nutrition market is segmented into powder, liquid, and semi-solid under the products segment. In 2021, the powder product segment accounted for approx. 52% of the U.S. clinical nutrition market share. The high adoption, new product innovation, and higher recommendation by professionals drive significant segmental growth and dominate the other two segments with higher industry share.

The liquid segment in the U.S. clinical nutrition market was valued at USD 3.08 billion in 2021. Liquid form clinical nutrition products deliver enteral and parenteral nutrition therapy. Ready-to-drink is a significant category in the liquid form clinical nutrition product category and is trending in the industry. Their increasing energy drink use in sports and physical activities and rapid energy boosting accelerate high segmental growth.

Segmentation by Products

Powder
Liquid
Semi-solid

INSIGHTS BY AGE GROUP

By age group, the infant and toddlers segment shows lucrative opportunities and is growing at a CAGR of 6.61% during the forecast period. The infant and toddler population is a rapidly growing segment in the U.S. clinical nutrition market. Further, the child and teenage segment accounted for a 30.83% industry share and dominated the other segments.

Opportunities for Industry Growth in the US by Child & Teenage 2021

In the US high-school students, only 9% meet the daily fruit intake recommendations remaining are some who consume fruits or very low consumption.
Only 2% of US children adopt and stick to the recommended vegetable guidelines.
The higher consumption of added sugar and unhealthy daily eating habits accounted for children and teenage (2 to 19 age) up to 16% of their total daily calories.

Segmentation by Age Group

Infant & Toddler
Children and teenagers
Adult
Geriatric

INSIGHTS BY APPLICATION

Malnutrition is one of the major concerns addressed in the US population. Due to the increasing prevalence of various chronic conditions such as obesity/overweight, diabetes, hypertension, GI disorders, CVD, and others led to malnutrition in hospitalized as well as the general population and demand for clinical nutrition. In 2021, the malnutrition segment accounted for a 42.01% higher U.S. clinical nutrition market share and dominated other segments. Currently, more than 40 million US people and around 12 million children are food insure. Many US-based families face poverty and hunger challenges in areas where unprocessed and fresh healthy food is unavailable or sometimes expensive.

Cancer patients are likely to lose weight due to less eating due to stress, pain, diagnosis and treatments, nausea, and test change. Cancer-related malnutrition affects one out of three cancer patients. The U.S. clinical nutrition market by cancer is growing at a CAGR of 6.96% during the forecast period. The demand for good nutrition is significant if the person has cancer due to its illness, and treatments can impact food consumption. Also, cancer treatments impact how the body tolerates certain foods and uses nutrients. If that severe condition appears in the patients, professionals recommend clinical nutrition to the patients and deliver care.

Segmentation by Application

Malnutrition
Metabolic Disorders
Gastrointestinal disorders (GI)
Cancer
Others

INSIGHTS BY DISTRIBUTION CHANNEL

The U.S. clinical nutrition market by distribution channels is segmented into institutional sales channels, supermarkets and hypermarkets, pharmacies and drug stores, specialty stores, and online sales channels. In 2021, the institutional sales segment accounted for 45.53% industry share in the clinical nutrition market in the US. Institutional sales channels are emerging distribution channels for the clinical nutrition industry, which differ entirely from healthcare practitioner distribution channels. Some industry players came up with unique distribution channels to eliminate the delay and third-party interference in the supply of products.

The supermarket & hypermarket U.S. clinical nutrition market was valued at USD 2.07 billion in 2021. For clinical nutrition, supermarkets and hypermarket are large retail stores operated by self-services that offer milk-based formulas, energy drinks, ready-to-drink, and other clinical nutrition and dietary products recommended by professionals. On the other side, the hypermarket plays a vital role in clinical nutrition products sale. It is one-stop shopping where most of the required clinical nutrition products are available in large amounts, so small retailers or customers can buy them and drive the sale.

Segmentation by Distribution Channels

Institutional Sales Channels
Supermarkets and Hypermarkets
Pharmacies and Drug Stores
Specialty Stores
Online Channels
Others

INSIGHTS BY END-USER

With the increasing prevalence of malnutrition, metabolic disorders, cancer, GI disorders, and other medical conditions, the hospitalization rate also increased in the US. Hospitals play a vital role in oral, enteral, and parenteral clinical nutrition therapies and contribute to higher industry growth under the end-user segment. In 2021, hospital segments accounted for a 41.95% U.S. clinical nutrition market share. The increasing number of hospital stays led to a rising rate of malnutrition. In the US, millions of people have hospital stays annually and account for malnutrition care which significantly drives the adoption of clinical nutrition therapies in hospitals. The significant demand for oral nutrition supplements (ONS), specifically developed for energy, protein, and other nutrient delivery propels the significant segmental growth.

Homecare is one of the trending healthcare settings widely accepted in the US. After the emergence of the COVID-19 pandemic, most ICU patients and hospitalized patients prefer home nutrition therapies due to their benefits and keep matter with their comfort. Home care nutrition therapies give patients the best environment, showing the rapid recovery of chronically ill patients-the availability of home enteral and parenteral clinical nutrition therapy providers in the US fuel the industry's growth. The homecare U.S. clinical nutrition market is growing at a CAGR of 5.86% during the forecast period.

Segmentation by End-Users

Hospitals
Individuals
Home care
Long-term care facilities

VENDOR LANDSCAPE

Abbott, B. Braun Melsungen Ag, Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading players in the U.S. clinical nutrition market players, accounting for the higher industry share in the United States. On the other hand, emerging players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging industry players positively influences the competition in the clinical nutrition market in the US. The primary competition among the industry players accounted due to new product launches, emerging, and gold standard formulations.

Competition Among the Major Industry Players

Abbott's Ensure is one of the leading clinical nutrition products used in the U.S. clinical nutrition market. This product significantly drives the company's high customer base and delivers higher revenue yearly.
Danone is a leading industry player offering specialized nutrition comprising Advanced Medical Nutrition (AMN) and Early Life Nutrition solutions.
Perrigo Company is one of the leading companies offering store-brand self-care products, including toddler and infant formulas and pediatric and adult nutrition drinks.

Key Vendors

Abbott
B. Braun Melsungen Ag.
Baxter
Danone
Fresenius Kabi
Nestle
Perrigo Company
Reckitt Benckiser Group

Other Prominent Vendors

ADM
Ajinomoto Co
BASF SE
DSM
Envara Health
Glanbia plc
Hero Nutritionals
Hum Nutrition
Kendal Nutricare
Lonza
Lactalis Nutrition Sante
MEND
MediFood International SA
Primus Pharmaceuticals
SternLife GmbH & Co. KG
The Craft Heinz Company
Vivante Health
Wakefield-Vette

KEY QUESTIONS ANSWERED

1. What is the size of the U.S. clinical nutrition market?
2. What is the projected growth rate of the U.S. clinical nutrition market?
3. What are the trends in the U.S. clinical nutrition market?
4. Who are the key players in the U.S. clinical nutrition market?
5. Which product segment is expected to dominate the U.S. clinical nutrition market?

Product Code: ARZ221101

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY PRODUCTS
- 4.3.2 MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION
- 4.3.3 MARKET SEGMENTATION BY AGE GROUP
- 4.3.4 MARKET SEGMENTATION BY APPLICATION
- 4.3.5 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
- 4.3.6 MARKET SEGMENTATION BY END-USERS

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 PREMIUM INSIGHTS

9 MARKET OPPORTUNITIES & TRENDS

9.1 INNOVATION IN PERSONALIZATION AND TARGETED SOLUTIONS
9.2 INCREASING DEMAND FOR INFANT NUTRITION
9.3 ADVANCES IN NUTRITIONAL THERAPIES
9.4 SHIFT TOWARD HOME NUTRITIONAL CARE

10 MARKET GROWTH ENABLERS

10.1 GOVERNMENT INITIATIVES, INVESTMENTS, AND FUNDING FOR CLINICAL NUTRITION RESEARCH
10.2 INCREASING CHRONIC DISEASE PREVALENCE REQUIRES NUTRITIONAL SUPPORT
10.3 IMPACT OF COVID-19 ON CLINICAL NUTRITION

11 MARKET RESTRAINTS

11.1 SIDE EFFECTS AND COMPLICATIONS DUE TO CLINICAL NUTRITION
11.2 BARRIERS TO DELIVERING ENTERAL NUTRITION IN PEDIATRIC ICU
11.3 HIGH COST OF CLINICAL NUTRITION

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW
- 12.1.1 CLINICAL NUTRITION MARKET IN US: PRODUCT SEGMENTATION INSIGHTS
- 12.1.2 CLINICAL NUTRITION MARKET IN US: PRODUCT SEGMENTATION INSIGHTS
- 12.1.3 CLINICAL NUTRITION MARKET IN US BY APPLICATION
- 12.1.4 CLINICAL NUTRITION MARKET IN US BY AGE GROUP
- 12.1.5 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNEL
- 12.1.6 CLINICAL NUTRITION MARKET IN US BY END-USER
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY

13 ROUTE OF ADMINISTRATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 ORAL
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 ORAL PRODUCT MARKET BY ROUTE OF ADMINISTRATION
13.4 ENTERAL
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 ENTERAL PRODUCT MARKET BY AGE GROUP
13.5 PARENTERAL
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 PARENTERAL PRODUCT MARKET BY AGE GROUP

14 PRODUCT

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 POWDER
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
14.4 LIQUID
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
14.5 SEMI-SOLID
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST

15 AGE GROUP

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CHILD AND TEENAGER
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
15.4 ADULT
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
15.5 INFANT & TODDLER
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
15.6 GERIATRIC
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST

16 APPLICATION

16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 MALNUTRITION
- 16.3.1 MARKET OVERVIEW
- 16.3.2 MARKET SIZE & FORECAST
16.4 METABOLIC DISORDERS
- 16.4.1 MARKET OVERVIEW
- 16.4.2 MARKET SIZE & FORECAST
16.5 GASTROINTESTINAL DISEASES
- 16.5.1 MARKET OVERVIEW
- 16.5.2 MARKET SIZE & FORECAST
16.6 CANCER
- 16.6.1 MARKET OVERVIEW
- 16.6.2 MARKET SIZE & FORECAST
16.7 OTHERS
- 16.7.1 MARKET OVERVIEW
- 16.7.2 MARKET SIZE & FORECAST

17 DISTRIBUTION CHANNEL

17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 MARKET OVERVIEW
17.3 INSTITUTIONAL SALES
- 17.3.1 MARKET OVERVIEW
- 17.3.2 MARKET SIZE & FORECAST
17.4 SUPERMARKET & HYPERMARKET
- 17.4.1 MARKET OVERVIEW
- 17.4.2 MARKET SIZE & FORECAST
17.5 ONLINE CHANNELS
- 17.5.1 MARKET OVERVIEW
- 17.5.2 MARKET SIZE & FORECAST
17.6 PHARMACIES & DRUG STORES
- 17.6.1 MARKET OVERVIEW
- 17.6.2 MARKET SIZE & FORECAST
17.7 SPECIALTY STORES
- 17.7.1 MARKET OVERVIEW
- 17.7.2 MARKET SIZE & FORECAST
17.8 OTHERS
- 17.8.1 MARKET OVERVIEW
- 17.8.2 MARKET SIZE & FORECAST

18 END-USER

18.1 MARKET SNAPSHOT & GROWTH ENGINE
18.2 MARKET OVERVIEW
18.3 HOSPITALS
- 18.3.1 MARKET OVERVIEW
- 18.3.2 MARKET SIZE & FORECAST
18.4 INDIVIDUAL
- 18.4.1 MARKET OVERVIEW
- 18.4.2 MARKET SIZE & FORECAST
18.5 HOMECARE
- 18.5.1 MARKET OVERVIEW
- 18.5.2 MARKET SIZE & FORECAST
18.6 LONG-TERM CARE CENTERS
- 18.6.1 MARKET OVERVIEW
- 18.6.2 MARKET SIZE & FORECAST

19 COMPETITIVE LANDSCAPE

19.1 COMPETITION OVERVIEW
19.2 MARKET SHARE ANALYSIS
- 19.2.1 ABBOTT
- 19.2.2 B. BRAUN MELSUNGEN AG
- 19.2.3 BAXTER
- 19.2.4 DANONE
- 19.2.5 FRESENIUS KABI
- 19.2.6 NESTLE
- 19.2.7 PERRIGO COMPANY
- 19.2.8 RECKITT BENCKISER

20 KEY COMPANY PROFILES

20.1 ABBOTT
- 20.1.1 BUSINESS OVERVIEW
- 20.1.2 PRODUCT OFFERINGS
- 20.1.3 KEY STRATEGIES
- 20.1.4 KEY STRENGTHS
- 20.1.5 KEY OPPORTUNITIES
20.2 B. BRAUN MELSUNGEN AG
- 20.2.1 BUSINESS OVERVIEW
- 20.2.2 PRODUCT OFFERINGS
- 20.2.3 KEY STRATEGIES
- 20.2.4 KEY STRENGTHS
- 20.2.5 KEY OPPORTUNITIES
20.3 BAXTER
- 20.3.1 BUSINESS OVERVIEW
- 20.3.2 PRODUCT OFFERINGS
- 20.3.3 KEY STRATEGIES
- 20.3.4 KEY STRENGTHS
- 20.3.5 KEY OPPORTUNITIES
20.4 DANONE
- 20.4.1 BUSINESS OVERVIEW
- 20.4.2 PRODUCT OFFERINGS
- 20.4.3 KEY STRATEGIES
- 20.4.4 KEY STRENGTHS
- 20.4.5 KEY OPPORTUNITIES
20.5 FRESENIUS KABI
- 20.5.1 BUSINESS OVERVIEW
- 20.5.2 PRODUCT OFFERINGS
- 20.5.3 KEY STRATEGIES
- 20.5.4 KEY STRENGTHS
- 20.5.5 KEY OPPORTUNITIES
20.6 NESTLE
- 20.6.1 BUSINESS OVERVIEW
- 20.6.2 PRODUCT OFFERINGS
- 20.6.3 KEY STRATEGIES
- 20.6.4 KEY STRENGTHS
- 20.6.5 KEY OPPORTUNITIES
20.7 PERRIGO COMPANY
- 20.7.1 BUSINESS OVERVIEW
- 20.7.2 PRODUCT OFFERINGS
- 20.7.3 KEY STRATEGIES
- 20.7.4 KEY STRENGTHS
- 20.7.5 KEY OPPORTUNITIES
20.8 RECKITT BENCKISER GROUP
- 20.8.1 BUSINESS OVERVIEW
- 20.8.2 PRODUCT OFFERINGS
- 20.8.3 KEY STRATEGIES
- 20.8.4 KEY STRENGTHS
- 20.8.5 KEY OPPORTUNITIES

21 OTHER PROMINENT VENDORS

21.1 ADM
- 21.1.1 BUSINESS OVERVIEW
- 21.1.2 PRODUCT OFFERINGS
21.2 AJINOMOTO CO
- 21.2.1 BUSINESS OVERVIEW
- 21.2.2 PRODUCT OFFERINGS
21.3 BASF SE
- 21.3.1 BUSINESS OVERVIEW
- 21.3.2 PRODUCT OFFERINGS
21.4 DSM
- 21.4.1 BUSINESS OVERVIEW
- 21.4.2 PRODUCT OFFERINGS
21.5 ENVARA HEALTH
- 21.5.1 BUSINESS OVERVIEW
- 21.5.2 PRODUCT OFFERINGS
21.6 GLANBIA PLC
- 21.6.1 BUSINESS OVERVIEW
- 21.6.2 PRODUCT OFFERINGS
21.7 HERO NUTRITIONALS
- 21.7.1 BUSINESS OVERVIEW
- 21.7.2 PRODUCT OFFERINGS
21.8 HUM NUTRITION
- 21.8.1 BUSINESS OVERVIEW
- 21.8.2 PRODUCT OFFERINGS
21.9 KENDAL NUTRICARE
- 21.9.1 BUSINESS OVERVIEW
- 21.9.2 PRODUCT OFFERINGS
21.10 LONZA
- 21.10.1 BUSINESS OVERVIEW
- 21.10.2 PRODUCT OFFERINGS
21.11 LACTALIS NUTRITION SANTE
- 21.11.1 BUSINESS OVERVIEW
- 21.11.2 PRODUCT OFFERINGS
21.12 MEND
- 21.12.1 BUSINESS OVERVIEW
- 21.12.2 PRODUCT OFFERINGS
21.13 MEDIFOOD INTERNATIONAL SA
- 21.13.1 BUSINESS OVERVIEW
- 21.13.2 PRODUCT OFFERINGS
21.14 PRIMUS PHARMACEUTICALS
- 21.14.1 BUSINESS OVERVIEW
- 21.14.2 PRODUCT OFFERINGS
21.15 STERNLIFE GMBH & CO. KG
- 21.15.1 BUSINESS OVERVIEW
- 21.15.2 PRODUCT OFFERINGS
21.16 THE CRAFT HEAINZ COMPANY
- 21.16.1 BUSINESS OVERVIEW
- 21.16.2 PRODUCT OFFERINGS
21.17 VIVANTE HEALTH
- 21.17.1 BUSINESS OVERVIEW
- 21.17.2 PRODUCT OFFERINGS

22 REPORT SUMMARY

22.1 KEY TAKEAWAYS
22.2 STRATEGIC RECOMMENDATIONS

23 QUANTITATIVE SUMMARY

23.1 MARKET BY PRODUCT
23.2 MARKET BY ROUTE OF ADMINISTRATION
23.3 MARKET BY AGE GROUP
23.4 MARKET BY APPLICATION
23.5 MARKET BY DISTRIBUTION CHANNEL
23.6 MARKET BY END-USERS
23.7 ROUTE OF ADMINISTRATION MARKET BY AGE GROUP
- 23.7.1 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP
- 23.7.2 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP
- 23.7.3 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP

24 APPENDIX

24.1 ABBREVIATIONS